The mission of ASC is to take our licensed patented line of MASCs through FDA pre-clinical and clinical trials establishing medical devices, pharmaceuticals, and medical treatments approved for marketing. ASC plans to actively pursue commercialization of its tissue regeneration technologies which replace the need of donor cells. The MASCs will essentially become known as “cells in a bottle” providing a specified dose of adult stem cells for specific therapies, which is an enormous advantage over harvesting cells from a patient’s body. Our MASCs have the potential to produce a minimum of over two hundred therapeutic treatments.
Investor Relations Contact
Accredited investors should contact IR@ASCBio.com or fill out the form below to be contacted by ASC Bioscience, Inc. when the company makes available any offerings of the company’s common stock.
ASC Biosciences is currently seeking investors to fund the final stages of product development. We invite you to consider investing in ASC Biosciences and will be happy to provide you with our market analysis.